REGISTRAT-MAPI & Acceliant on Developing Acceliant EDC Platform's ePRO Capabilities
13 Oct, 2010
October 13 2010, Herndon, Virginia - Acceliant is pleased to announce that REGISTRAT-MAPI, a long term client of Acceliant eClinical suite, has agreed to serve as advisors in the development of the ePRO/mPRO module for Acceliant. REGISTRAT-MAPI has utilized Acceliant since 2007, for many of their Late Phase studies. REGISTRAT-MAPI, using their clinical experience and knowledge of the industry accumulated conducting Late Phase studies, will advise Trianz in defining and reviewing the ePRO module.
Stephen Webb, REGISTRAT-MAPI, President North America stated that, "since the majority of our late phase studies include collecting, analyzing and interpreting patient reported outcome (PRO) data to demonstrate product effectiveness and evidence based science, having these robust ePRO tools and web-based applications significantly contribute to successful conduct of these studies."
Acceliant V6.1, released earlier this year, and V6.2 scheduled for Q4 2010 release, already incorporates a number of functional enhancements identified by REGISTRAT-MAPI based on their unique PRO experience as the leading Global Late Phase CRO dedicated to 'real life' clinical research. Trianz and REGISTRAT-MAPI greatly value this mutually benefitted collaboration. The Acceliant ePRO module seamlessly integrates with the Acceliant eClinical Suite to expand the breadth of data collection channels and technology options.
Sri Manchala, President and CEO of Acceliant, adds, "Acceliant ePRO supports a rich set of features for patients to register, enroll and complete the necessary forms. Data capture applications include: Web, Smart Phones, Tablets, and IVRS. Additionally, the ePRO module provides sites with patient profiles, custom reports and real-time access to data." Acceliant will be demonstrating an initial version of the ePRO module at the 2010 Annual Meeting of the Society for Clinical Data Management (SCDM) in Minneapolis, MN
About Acceliant eClinical Suite
Acceliant eClinical Suite is competitive in meeting the challenges of today's dynamic market conditions. The Acceliant eClinical Suite is a pre-eminent offering that continues its 11-year history of providing innovative solutions for the life sciences industry. The Acceliant eClinical Suite is robust, scalable, and flexible. It has been proven by more than 350 Phase I-IV trials, covering all therapeutic areas and medical device trials. Engineered for agility, our service model differentiators enable us to implement and deploy in response to the data, functional, and analytic needs of clinical trials.